Resmetirom in Patients With MASH and HFpEF
Resmetirom in Patients With MASH and HFpEF
Not yet recruiting · NCT07830758 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Resmetirom in Patients With MASH and HFpEF | Heart Failure With Preserved Ejection Fraction (HFPEF); MASH - Metabolic Dysfunction-Associated Steatohepatitis | Not yet recruiting | Phase 1 | 2026-09-21 | NCT07830758 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Madrigal Pharmaceuticals, Inc. | 9 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||